- Home
- SCYX vs EDRY Comparison
SCYX vs EDRY Comparison
Compare SCYX & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- EDRY
- Stock Information
- Founded
- SCYX 1999
- EDRY 2018
- Country
- SCYX United States
- EDRY Greece
- Employees
- SCYX N/A
- EDRY N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- EDRY Marine Transportation
- Sector
- SCYX Health Care
- EDRY Consumer Discretionary
- Exchange
- SCYX Nasdaq
- EDRY Nasdaq
- Market Cap
- SCYX 50.3M
- EDRY 57.9M
- IPO Year
- SCYX 2014
- EDRY N/A
- Fundamental
- Price
- SCYX $1.18
- EDRY $14.00
- Analyst Decision
- SCYX Buy
- EDRY Strong Buy
- Analyst Count
- SCYX 1
- EDRY 1
- Target Price
- SCYX N/A
- EDRY $30.00
- AVG Volume (30 Days)
- SCYX 165.3K
- EDRY 6.8K
- Earning Date
- SCYX 11-06-2024
- EDRY 11-19-2024
- Dividend Yield
- SCYX N/A
- EDRY N/A
- EPS Growth
- SCYX N/A
- EDRY N/A
- EPS
- SCYX N/A
- EDRY N/A
- Revenue
- SCYX $8,566,000.00
- EDRY $65,085,280.00
- Revenue This Year
- SCYX N/A
- EDRY $59.92
- Revenue Next Year
- SCYX $145.59
- EDRY $14.08
- P/E Ratio
- SCYX N/A
- EDRY N/A
- Revenue Growth
- SCYX N/A
- EDRY 39.04
- 52 Week Low
- SCYX $1.15
- EDRY $11.09
- 52 Week High
- SCYX $3.07
- EDRY $24.84
- Technical
- Relative Strength Index (RSI)
- SCYX 28.95
- EDRY 17.32
- Support Level
- SCYX $1.25
- EDRY $11.09
- Resistance Level
- SCYX $1.37
- EDRY $15.60
- Average True Range (ATR)
- SCYX 0.06
- EDRY 0.85
- MACD
- SCYX -0.01
- EDRY -0.08
- Stochastic Oscillator
- SCYX 9.26
- EDRY 44.06
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About EDRY EuroDry Ltd.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.